A recent survey found that even though nearly half of Canadians do not think it is safe to receive the new coronavirus vaccine, most people say they will receive the vaccine anyway.

KPMG conducted a survey of 2002 Canadians between December 11 and 15 and found that eight out of ten Canadians said that if the vaccine were provided to them in the next three months, they would be willing to receive the new COVID-19 vaccine. However, in the same survey, only 53% of respondents believed that vaccination was completely safe.

Another quarter of the respondents worry that vaccination may not be completely safe, but said they are still willing to accept this risk in order to resume their daily lives and start the economic phase.

One-fifth of the interviewees said that they would not get the vaccine because they have concerns about the safety of the vaccine and its launch strategy.

Canadians also stated that the number one factor that can make them feel safe is to “clearly guarantee” that the medical staff who provided the vaccine have correctly recorded, tracked and reported potential side effects to public health officials (97%), followed by the vaccine program. Full transparency (96%) and trust that vaccine approval is based solely on health factors (96%).

So far, the biggest worry Canadians have about the vaccine program is that the vaccine has been put on the market without safety confirmation (63%). Other issues of common concern include barriers between jurisdictions leading to delays in distribution (46%), quality problems of vaccines produced abroad (45%), and insufficient tracking systems between all levels of the medical system, leading to oversupply Or insufficient and unable to know who has been vaccinated (42%).

Other findings include that 85% of the respondents support a nationwide COVID-19 vaccine tracking system, 7/10 of the respondents believe that having “Made in Canada” solutions and operational strategies are essential, and nearly 2/3 of the respondents believe that effective and efficient vaccine rollout plans must involve the Canadian military, and 96% of people want a “clear guarantee” that their personal information is protected.

Jerome Thirion, National Head of Supply Chain Management at KPMG, said: “It is vital that all digital systems for tracking viral vaccines must be integrated and aligned to ensure that people can get the correct second dose of vaccine, adverse reactions can be tracked, and The progress of improving immunity can be monitored.”

Categorized in: